Precigen (PGEN) Common Equity (2016 - 2025)
Historic Common Equity for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $41.9 million.
- Precigen's Common Equity fell 2439.32% to $41.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.9 million, marking a year-over-year decrease of 2439.32%. This contributed to the annual value of $38.5 million for FY2024, which is 6749.9% down from last year.
- Per Precigen's latest filing, its Common Equity stood at $41.9 million for Q3 2025, which was down 2439.32% from -$36.8 million recorded in Q2 2025.
- Precigen's Common Equity's 5-year high stood at $184.1 million during Q1 2023, with a 5-year trough of -$36.8 million in Q2 2025.
- Its 5-year average for Common Equity is $95.4 million, with a median of $107.3 million in 2021.
- Its Common Equity has fluctuated over the past 5 years, first surged by 22133.54% in 2021, then crashed by 18519.57% in 2025.
- Over the past 5 years, Precigen's Common Equity (Quarter) stood at $107.3 million in 2021, then grew by 17.62% to $126.3 million in 2022, then decreased by 6.15% to $118.5 million in 2023, then crashed by 67.5% to $38.5 million in 2024, then grew by 8.71% to $41.9 million in 2025.
- Its Common Equity was $41.9 million in Q3 2025, compared to -$36.8 million in Q2 2025 and -$14.1 million in Q1 2025.